EHNA (erythro-9-(2-hydroxy-3-nonyl)adenine) is a potent adenosine deaminase inhibitor, which also acts as a phosphodiesterase inhibitor that selectively inhibits phosphodiesterase type 2 (PDE2).

CAS：59262-86-1
中文别名：
英文别名：erythro-9-(2-hydroxy-3-nonyl)adenine;1.4.5-Trihydroxy-7-methoxy-2-methyl-anthrachinon;Erythroglaucine;1,4,8-trihydroxy-6-methoxy-3-methylanthraquinone;Erythroglaucin (6-Methyl-catenarin);Erythroglaucin;Erythroglancin;erythrohydroxynonyladenine;1,4,5-trihydroxy-7-methoxy-2-methyl-9,10-anthraquinone;9,10-Anthracenedione,1,4,5-trihydroxy-7-methoxy-2-methyl;1,4,5-trihydroxy-7-methoxy-2-methyl-anthraquinone;ANTHRAQUINONE,7-METHOXY-2-METHYL-1,4,5-TRIHYDROXY;
分子式：C14H23N5O
分子量：277.365
精确质量：277.19
Psa：89.85
Logp：2.882